Osteoporosis, Postmenopausal: Clinical Trials

2 trials for Osteoporosis, Postmenopausal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Osteoporosis, Postmenopausal: new trials by email Literature Review of Osteoporosis, Postmenopausal trials Research Report on Osteoporosis, Postmenopausal

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of GLP-1 Receptor Agonists on Trabecular Bone Score
GLP-1 receptor agonist - Osteoporosis, Postmenopausal, Diabetes Mellitus, Type 2
Phase 2TerminatedUniversity of Mississippi Medical Center52021-11-092025-06-13
Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women
VSL#3, Placebo - Menopausal Osteoporosis
Phase 2TerminatedEmory University352017-10-012020-03-04

Narrower conditions

Diabetes Mellitus, Type 2 (1)

Broader conditions

Bone Diseases (2)  ·  Bone Diseases, Metabolic (2)  ·  Metabolic Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Osteoporosis (2)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)

Sponsors

Emory University (1)  ·  University of Mississippi Medical Center (1)

Countries

United States (2)

Top investigators

Roberto Pacifici (1)  ·  Vishnu V Garla, MD (1)